Anderson, South Carolina • Velocity Clinical Research
Phone: (864) 965-0190
Velocity is enrolling adults with COPD and cardiopulmonary risk factors, or at high risk of developing cardiopulmonary disease risk factors for a research study evaluating severe cardiac and pulmonary outcomes
This study will evaluate the effect of triple ICS/LAMA/LABA inhalers in comparison to LAMA/LABA inhalers on cardiopulmonary outcomes in participants with cardiopulmonary risk.
For more information, complete the form on this page. After you submit your information, a Velocity enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.
©2023 Velocity Clinical Research | All Rights Reserved | Privacy Policy